Modelling outbreak response strategies for preventing spread of emergent Neisseria gonorrhoeae strains in men who have sex with men in Australia
暂无分享,去创建一个
David Bruce Lewis | J. Kaldor | R. Guy | A. McNulty | M. Law | D. Whiley | J. Wood | Q. Duan | D. Templeton | B. Donovan | S. McGregor | D. Regan | C. Selvey | M. Maley | B. Hui | C. Carmody | S. Mcgregor | M. M. Lahra
[1] M. Unemo,et al. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] J. Hocking,et al. Models of gonorrhoea transmission from the mouth and saliva. , 2019, The Lancet. Infectious diseases.
[3] Monica Lahra,et al. Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history. , 2019, The Journal of antimicrobial chemotherapy.
[4] D. Lewis. New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance. , 2019, Sexual health.
[5] T. Street,et al. P675 Two recent cases of extensively drug-resistant (XDR) gonorrhoea in the united kingdom linked to a european party destination , 2019, Poster Presentations.
[6] J. Hocking,et al. Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: a cross-sectional study in men who have sex with men , 2019, Sexually Transmitted Infections.
[7] T. Street,et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] D. Eyre,et al. Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] R. Guy,et al. Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay and bisexual men attending Australian sexual health clinics. , 2019, Sexual health.
[10] Monica Lahra,et al. Treatment for pharyngeal gonorrhoea under threat. , 2018, The Lancet. Infectious diseases.
[11] M. Unemo,et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] W. Demczuk,et al. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain , 2018, Emerging infectious diseases.
[13] M. Gambhir,et al. Neisseria gonorrhoeae Transmission Among Men Who Have Sex With Men: An Anatomical Site-Specific Mathematical Model Evaluating the Potential Preventive Impact of Mouthwash , 2017, Sexually transmitted diseases.
[14] D. Lewis,et al. Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance? , 2017, The Journal of antimicrobial chemotherapy.
[15] Monica Lahra,et al. Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia. , 2017, The Lancet. Infectious diseases.
[16] C. Bradshaw,et al. Duration of gonorrhoea and chlamydia infection at the pharynx and rectum among men who have sex with men: a systematic review. , 2016, Sexual health.
[17] J. Hocking,et al. Early presentation of symptomatic individuals is critical in controlling sexually transmissible infections. , 2015, Sexual health.
[18] J. Hocking,et al. Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model , 2015, Sexually Transmitted Infections.
[19] M. Unemo,et al. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.
[20] M. Russell,et al. New Concepts in Immunity to Neisseria Gonorrhoeae: Innate Responses and Suppression of Adaptive Immunity Favor the Pathogen, Not the Host , 2011, Front. Microbio..
[21] S. Tabrizi,et al. Is it time to move to nucleic acid amplification tests screening for pharyngeal and rectal gonorrhoea in men who have sex with men to improve gonorrhoea control? , 2011, Sexual health.
[22] C. Bourne,et al. Is screening asymptomatic men who have sex with men for urethral gonorrhoea worthwhile? , 2010, Sexual health.
[23] J. Tapsall,et al. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006. , 2007, The Journal of antimicrobial chemotherapy.
[24] S. Garland,et al. Re-infection of Neisseria gonorrhoeae and Chlamydia trachomatis infections among men who have sex with men , 2006, International journal of STD & AIDS.
[25] M. Salter,et al. The Health in Men and Positive Health cohorts A comparison of trends in the health and sexual behaviour of HIV-negative and HIV-positive gay men, 2002-2005 , 2006 .
[26] P. Moodley,et al. Ciprofloxacin-resistant gonorrhoea in South Africa , 2005, The Lancet.
[27] J. Zenilman,et al. Gonorrhoea reinfection in heterosexual STD clinic attendees: longitudinal analysis of risks for first reinfection , 2003, Sexually transmitted infections.
[28] M. Mayo,et al. Limited Local and Systemic Antibody Responses toNeisseria gonorrhoeae during Uncomplicated Genital Infections , 1999, Infection and Immunity.
[29] K. Holmes,et al. A trial of minocycline given after exposure to prevent gonorrhea. , 1979, The New England journal of medicine.